This week, Novartis announced that it would be ending its research program designed to discover new antibiotics. The announcement was greeted with great concern, as “superbugs” resistant to our current arsenal of antibiotics, are a growing threat. In the early 1900s, infection was the primary cause of death. After improvements in sanitation, nutrition, and the […] The post Rising Development Costs Are Causing Drug Companies to Abandon Antibiotic Research appeared first on Official Site of Dr. Mary Ruwart.

You need to be logged in to share items to Gab.

Copyright © 2020 Gab AI, Inc.
Terms of Service